Megan E. Barra

Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy

Megan E. Barra, John Fanikos, Jean M. Connors et al. · The American Journal of Medicine · 2016 · 140 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages

Megan E. Barra, Alvin S. Das, Bryan D. Hayes et al. · Journal of Thrombosis and Haemostasis · 2020 · 110 citations

Medicine, Hematology, Pharmacotherapy +14

Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit

Brian L. Edlow, Megan E. Barra, David Zhou et al. · Neurocritical Care · 2020 · 65 citations · Full text

Life Sciences, Health Informatics, Neuroscience +15

High incidence of neutropenia in patients with prolonged ceftaroline exposure

Kari J. Furtek, David W. Kubiak, Megan E. Barra et al. · Journal of Antimicrobial Chemotherapy · 2016 · 55 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +9

Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients

Charlene Ong, Meghan R. Hutch, Megan E. Barra et al. · Neurocritical Care · 2018 · 48 citations

Medicine, Neurology, Neurocritical Care +11